Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Home
Investire
Obbligazioni
Europa
EU
2.97% 24/01/32 2.97% 24/01/32 (ACAPI)
2.97% 24/01/32 2.97% 24/01/32 (ACAPI) Notizie

2.97% 24/01/32 2.97% 24/01/32 (ACAPI)

100,00

0,00

(0,00%)

Chiuso 06 Giugno 5:30PM

Il tuo punto di riferimento per quotazioni in tempo reale, idee e discussioni live.

Premium

0 articoli trovati

DTGoody

DTGoody 1 minuto fa

Yes, I was playing that Damn VMH* which appears I jinxed as usual! That's another one pissing me off! LOL I could have bought a ton more shares here if I reacted better to the news and switched things around if you know what I mean. Instead, I had my thumb up my Rear while this Gem keeps running! LO

Myth

Myth 2 minuti fa

Hand Of Fate · The Rolling Stones

https://www.youtube.com/watch?v=3RGhtDjup38

badshah

badshah 2 minuti fa

School teacher...but you have no shares...so why the interest????

dewophile

dewophile 3 minuti fa

I’ll check it out thanks. A key point is that ketones can rise even when glucose levels are within range. I’m not sure the commercial opportunity but it sounds not only limited to type 1 diabetics. It also seems like dexcom has greater market share in intensive insulin users and this is the populati

Myth

Myth 3 minuti fa

The Rolling Stones - One Hit (To The Body)

https://www.youtube.com/watch?v=dx2WRQLSIew

1plus1

1plus1 3 minuti fa

A Once in a lifetime opportunity, BIEI will make history next week in Mexico, World Cup and we sponsor the product … possible dream come true

jerkviewer

jerkviewer 3 minuti fa

i would love to know what he thinks our chances are

jerkviewer

jerkviewer 4 minuti fa

it might not be such a longshot....it definitely would change the valuation....nas will hopefully expand on that topic on the cc

eur06

eur06 5 minuti fa

ok it’ll be fine to wait, no rush from me.
GLND

1plus1

1plus1 8 minuti fa

LET'S HOPE THEY WILL USE THE PRODUCTS IN FIFFA CUP NEXT WEEK >> THIS WILL BE SWEEEEEEEEEEET AND OVER .10+ CENTS

FOFreddie

FOFreddie 9 minuti fa

Ackman is a billionaire friend who would probably this resolved ASAP. John Paulson is a billionaire friend who also probably wants this resolved ASAP. They really need to come out with a Housing Plan ASAP as you mentioned. Also - why would Trump want to leave any money on the table for the nex

DTGoody

DTGoody 9 minuti fa

Why would Cohen be involved with ENCC??? I'm sorry, but I don't see the connection between him and ENCC.

DTGoody

DTGoody 11 minuti fa

We will be on entirely differently exchange then!

flipper44

flipper44 11 minuti fa

NWBO was entrusted with this technology well over decades ago. Their perseverance is commendable, but their execution, communication, morphing plans, spending, and red zone efficiency, and that of MHRA, are reasonably subject to scrutiny.

GR8 Dad

GR8 Dad 11 minuti fa

If you ride the o t c you're gonna lose some money, even a child knows that.

Make sure your winners are bigger than your losers.That's the only way to play it.

The o t c is the world's largest casino, where the only game is liars poker.

Riding many, many,

Myth

Myth 12 minuti fa

Blow Wind Blow · Eric Clapton

https://www.youtube.com/watch?v=aE-QoPDxijc

DewDiligence

DewDiligence 13 minuti fa

Berobenatide—dosed monthly—appears_competitive_with_weekly Zepbound/Wegovy in efficacy/tolerability—see slide 7 at the link in #msg-177679183.

Berobenatide (f/k/a ‘3944) is the lead compound from PFE’s weight-loss pipeline acquired in the Metsera buyout (#msg-176942527).

joe botts

joe botts 13 minuti fa

tisdal

tisdal 14 minuti fa

Nice Job on the Research CW. That opened my eyes to truly understand what the GARB Report's purpose was. That GARB Report was a preliminary document to establish hydrocarbon potential justifying the 3D Seismic, and after analyzing that data, if drilling would be justifiable.

The sta

FOFreddie

FOFreddie 15 minuti fa

The Brydon Fisher lawsuit was a Derivative lawsuit which would have returned the damages back to Fannie and Freddie for the benefit of shareholders. The Lamberth/Berkeley lawsuit is a Class Action but the issue so far is that damages were severely limited. We wait for the Decision on Restitution

DewDiligence

DewDiligence 18 minuti fa

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

jour_trader

jour_trader 18 minuti fa

Would certainly be astronomical, just don’t think the odds are in our favor. We’ll know soon enough via lawsuit or cc if paragraph IV was pursued.

DewDiligence

DewDiligence 19 minuti fa

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

JamesF1

JamesF1 19 minuti fa

I look at the possibility of Elite successfully getting a paragraph 4 approval for Eliquis as a long shot. Long shots occasionally come in.

2.97% 24/01/32 2.97% 24/...

Procter and Gamble

Tasman Resources

Momentum Multi-asset Value

Vanguard Retirement Inco...

Aptevo Therapeutics

Janus Henderson Net Zero...

Intercorp Financial Serv...

Ci Global Alpha Innovato...

Abeona Therapeutics

iShares MSCI BIC ETF

Delayed Upgrade Clock

Assistenza: support@advfn.it

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN

Hai già un account? Accedi

Non hai un account? Registrati

Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.